RPS26P35

Across TCGA pan-cancer cohorts, RPS26P35 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPS26P35’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS26P35 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS26P35 is over-expressed in tumor, although a few such as PAAD and READ show the opposite, repressed pattern.

KIRC, PAAD, and READ are the cancer types where RPS26P35 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS26P35 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.087	.030	4	view →
PAAD	Female	All	−0.270	.046	2	view →
READ	All	II,III,IV	−0.222	.037	2	view →
HNSC	All	All	+0.100	.020	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RPS26P35–KIRC

Open the KIRC breakdown →